Novartis
-
FDA Gives Approval To Novartis Drug Combo For Skin Cancer
-
Novartis Cancer Drug Beneficial To Parkinson's Disease Patients, Reveals Early Stage Trial
-
Swiss Drug Maker Novartis To Invest Additional $15 Million In Israel's Gamida Cell
-
Opdivo And Cometriq Drugs Proven More Effective Than Novartis' Afinitor As Advanced Kidney Cancer Treatment
-
Novartis Launches Portfolio For Low Cost Medicines For Low To Middle Income Countries
-
Novartis Anticancer Drug Farydak Gets EU Thumbs Up
-
Google Teams Up With Sanofi To Improve Diabetes Management And Treatment
-
Novartis Odomzo Skin Cancer Drug Given FDA Nod Of Approval
-
Novartis' Entresto For Heart Failure Might Cost $4,500 A Year: What You Should Know About Heart Failure
-
US Wants Novartis To Pay $3.35 Billion Fine For Drug Kickbacks
-
Novartis Shows Long-Term Benefits Of Psoriasis Drug Cosentyx In New Set Of Clinical Data
-
European Commission Approves Novartis Lung Cancer Drug Zykadia
Most Popular
